Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials
Crossref DOI link: https://doi.org/10.1007/s40121-017-0171-0
Published Online: 2017-09-22
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mehta, Darshan A. http://orcid.org/0000-0002-1149-5673
Cohen, Eric
Charafeddine, Mariem
Cohen, Daniel E.
Bao, Yanjun
Sanchez Gonzalez, Yuri
Tran, Tram T.
Funding for this research was provided by:
AbbVie